Ciba turns down Biosignal compounds
Wednesday, 06 August, 2008
Global specialty chemical company Ciba Corporation has decided to stop testing Biosignal's [ASX: BOS] anti-microbial industrial compounds, citing major issues incorporating the product into theirs.
Ciba was evaluating whether it could incorporate the compounds into its PVC plastic and coatings, but found that doing so resulted in high temperatures during the processing stage and incompatibility with other components.
Representatives for Biosignal said the decision did not alter expectations for the viability of the compounds, stating that it still had evaluation agreements in place with a number of companies.
These include oil producer ConocoPhillips, sanitation product manufacturers Saraya Co, and leading agrichemicals and animal health companies.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...

